![Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial - The Lancet Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/74d46dd9-c12b-4205-93e2-b91d31653a74/gr1.gif)
Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial - The Lancet
![PDF) Real-World Characterization of the Portuguese Population Living with HIV who Initiated Raltegravir Based-Regimens: The REALITY Study PDF) Real-World Characterization of the Portuguese Population Living with HIV who Initiated Raltegravir Based-Regimens: The REALITY Study](https://i1.rgstatic.net/publication/359495382_Real-World_Characterization_of_the_Portuguese_Population_Living_with_HIV_who_Initiated_Raltegravir_Based-Regimens_The_REALITY_Study/links/62dd137c82bb4729929f20ad/largepreview.png)
PDF) Real-World Characterization of the Portuguese Population Living with HIV who Initiated Raltegravir Based-Regimens: The REALITY Study
![Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: e-Posters | European Journal of Human Genetics Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: e-Posters | European Journal of Human Genetics](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41431-023-01339-3/MediaObjects/41431_2023_1339_Fig1_HTML.png)